Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease: a subpopulation analysis of phase 3 induction and maintenance studies

Background/Aims: Efficacy and safety of ustekinumab were evaluated in a Japanese subpopulation with moderately to severely active Crohn's disease (CD) in UNITI-1, UNITI-2 and IM-UNITI studies and results were compared with the overall population.Methods: Overall, patients in UNITI-1 (Japan, n=5...

Full description

Bibliographic Details
Main Authors: Toshifumi Hibi, Yuya Imai, Yoko Murata, Nobuko Matsushima, Richuan Zheng, Christopher Gasink
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2017-10-01
Series:Intestinal Research
Subjects:
Online Access:https://doi.org/10.5217/ir.2017.15.4.475